AxoGen CEO Karen Zaderej Interview on Clear Channel Business Talk Radio DFW1190AM by Michael Yorba
December 13 2013 - 2:38PM
Marketwired
AxoGen CEO Karen Zaderej Interview on Clear Channel Business Talk
Radio DFW1190AM by Michael Yorba
Interview Today at 3:45PM EST -- Streamed via iHeart Radio
ALACHUA, FL--(Marketwired - Dec 13, 2013) - AxoGen, Inc.
(NASDAQ: AXGN), a leader in the science and commercialization of
surgical solutions for peripheral nerve repair, today announced CEO
Karen Zaderej will be interviewed live today at 3:45pm EST on Clear
Channel's business talk radio show "The Trader Network" by host
Michael Yorba.
Tune in today to listen to live on-air interview:
Live Link: http://www.iheart.com/live/4276/?autoplay=true Date:
Dec 13th, 2013 Time: 2:45pm CST | 3:45pm EST | 12:45pm PST Network:
Clear Channel Show: The Trader Network Station: DFW 1190AM Host:
Michael Yorba
The interview will cover:
- How AxoGen is changing the way the world thinks about nerve
repair.
- The over $1.6 billion market for peripheral nerve repair in the
United States and the nearly 1 million nerve surgeries performed
annually.
- AxoGen's full suite of nerve repair products including Avance®
Nerve Graft, the only commercially available processed nerve
allograft; AxoGuard® Nerve Protector; and AxoGuard® Nerve
Connector.
- AxoGen's mission to create a world where all patients are
offered choices for surgical repair of peripheral nerve.
- AxoGen's recent up listing to NASDAQ (AXGN) and its 49% revenue
growth reported for the Third Quarter of 2013
About Clear Channel Clear Channel Media and Entertainment's more
than 840 radio stations offer programming nationwide. Individual
station brands connect with diverse audiences in local markets
across the country. DFW1190AM.com Dallas-Ft. Worth, TX
www.clearchannel.com
About Michael Yorba Michael Yorba -- featured host of Clear
Channels DFW 1190AM in Dallas-Ft. Worth. For the past six years he
has been integrally involved with the media industry in various
capacities including building an IPTV Network, developing,
producing and hosting a daily one hour talk show called Commodity
Classics and then later The Traders Network, defined as an audience
empowered interactive financial program that has been broadcast
live on internet television and radio. His focus has been on
derivative portfolio analysis for individual and corporate clients
through the use of futures and futures options, managed funds, and
Forex. www.yorbamedia.com.
About AxoGen, Inc. AxoGen (NASDAQ: AXGN) is a leading
regenerative medicine company dedicated to advancing the science
and commercialization of peripheral nerve repair solutions. The
Company's innovative approach to regenerative medicine has resulted
in first-in-class products that will define their product
categories. AxoGen's products offer a full suite of surgical nerve
repair solutions including Avance® Nerve Graft, the only
off-the-shelf commercially available processed nerve allograft for
bridging severed nerves without the comorbidities associated with a
second surgical site, AxoGuard® Nerve Connector, a porcine
submucosa ExtraCellular Matrix (ECM) coaptation aid for tensionless
repair of severed nerves, and AxoGuard® Nerve Protector, a porcine
submucosa ECM product used to wrap and protect injured peripheral
nerves and reinforce the nerve reconstruction while preventing soft
tissue attachments.
AxoGen is the parent of its wholly owned operating subsidiary,
AxoGen Corporation. Avance® Nerve Graft is processed in the United
States by AxoGen. AxoGuard® Nerve Connector and AxoGuard® Nerve
Protector are manufactured in the United States by Cook Biotech
Incorporated, West Lafayette, Indiana, and are distributed
exclusively by AxoGen. www.AxoGenInc.com or follow us on
twitter @AxoGen.
Company Contact: AxoGen, Inc. Greg Freitag CFO & General
Counsel Tel: +1 (612) 619-6324 InvestorRelations@AxoGenInc.com
Press | Media Contact Matthew BIRD President MUNCmedia Public
Relations Tel: (917) 409-8211 Email: matt.bird@muncmedia.com A
www.1800PublicRelations.com PR Event
Axogen (NASDAQ:AXGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Axogen (NASDAQ:AXGN)
Historical Stock Chart
From Apr 2023 to Apr 2024